Generate a tailored SOP for Dr. Joel Pekow. Improve your application with a focused, well-structured draft.
Joel Pekow is an Associate Professor in the Department of Medicine-Gastroenterology at the University of Chicago. His primary focus is on investigating the mechanisms and predictors of disease progression and the response to therapy in patients with inflammatory bowel disease (IBD) and colon cancer. With a background in clinical medicine, he has directed various research activities, including innovative studies funded by the NIH. His research interests include elucidating molecular pathways in IBD and neoplasia using human colonoids, as well as examining the role of microRNA regulatory networks in predicting colon carcinogenesis associated with IBD. Pekow has published extensively in the field, contributing to a better understanding of the physiological changes in IBD and cancer development. He is known for his collaborative research efforts, having worked with numerous co-authors in the field, and has drawn attention from various scientific outlets.
University of Chicago • Chicago, IL
Pekow focuses on research related to inflammatory bowel diseases and colon cancer, particularly the mechanisms of disease progression and therapeutic responses.
Department of Philosophy